Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells.
Phetcharat Phanthong1, Hadas Raveh-Amit, Tong Li
1Biotalentum Ltd., Godollo, 2100, Hungary.
Biogerontology
|August 22, 2013
Summary
Induced pluripotent stem cells (iPSCs) hold promise for regenerative medicine, but aging hinders reprogramming efficiency. Understanding the link between aging and iPSC reprogramming is crucial for future cell therapies.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Aging research
Background:
- Induced pluripotent stem cells (iPSCs) offer revolutionary potential for regenerative medicine, disease modeling, and drug screening.
- Current applications face challenges including low reprogramming efficiency and safety concerns like genomic integration and tumor formation.
- Cellular aging is increasingly recognized as a significant barrier to efficient iPSC generation.
Purpose of the Study:
- To review the molecular pathways connecting cellular aging and reprogramming efficiency.
- To explore whether the reprogramming process rejuvenates age-associated molecular and cellular characteristics.
- To discuss current advancements in iPSC-based models for studying aging.
Main Methods:
- Literature review of molecular pathways linking aging and iPSC reprogramming.
- Analysis of studies investigating the rejuvenating effects of reprogramming on aged cells.
- Examination of iPSC-based models used in aging research.
Main Results:
- Aging is identified as a key factor contributing to reduced reprogramming efficiency in somatic cells.
- The relationship between aging and reprogramming involves complex molecular signaling pathways.
- Reprogramming may reverse some, but not all, age-related cellular changes.
Conclusions:
- Addressing the impact of aging on reprogramming efficiency is essential for advancing iPSC-based therapies.
- Further research is needed to fully understand the rejuvenating potential of iPSCs and their application in aging studies.
- iPSC technology provides valuable tools for investigating physiological and premature aging mechanisms.
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.